The U.S. Department of the Army Medical Command awarded The Leland Stanford Junior University (Stanford University) a $1,045,651 Project Grant on September 30, 2024 under the Military Medical Research and Development program (CFDA 12.420). The funding will support research to develop novel statistical methods for integrating high-dimensional clinical markers to evaluate treatment efficacy in amyotrophic lateral sclerosis (ALS) clinical trials. This research aims to transform health care for...
The federal Project Grant award of $4,232,760.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Leland Stanford Junior University (Stanford University). The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the public, with a focus on innovative research to address critical health challenges. The grant will fund research over a 4-year period from June...
The Defense Health Agency awarded The Leland Stanford Junior University a $1,500,084 project grant under the Military Medical Research and Development program to support research on detecting cartilage surface degeneration using photon counting CT and solute transport modeling. This grant will fund research from July 1, 2023 through June 30, 2027 aimed at transforming military and public health care through innovative medical solutions applicable to battlefield conditions. The Military Medical...
The U.S. Department of Defense's Defense Health Agency (DHA) awarded a $750,000 Project Grant to Stanford University to implement a spatial and single-cell multiplexed platform for the development of targeted therapies for vascularized composite allotransplantation. The funding is provided through the Military Medical Research and Development (CFDA 12.420) federal grant program, which supports advanced biomedical research to transform healthcare for military service members and the broader...
The Leland Stanford Junior University was awarded a $4.72 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from March 2021 through March 2025 relating the interplay of tumor function and host response to clinical outcome in triple negative breast cancer. Through this award, Stanford University researchers will investigate medical solutions for breast cancer on the battlefield and...
This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,419,063.00 to The Leland Stanford Junior University (Stanford University) to conduct research on synaptic retinoic acid signaling in spinal cord homeostatic plasticity and mechanical allodynia. The research, which will take place at Stanford University from September 1, 2023 to August 31, 2027, aims to transform healthcare for U.S. Service Members and...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $469,381 to The Leland Stanford Junior University to conduct research on "Engineering Cytotoxic Lymphocytes to Infiltrate Ovarian Cancer Tumors via Metabolite-Sensing Receptors". The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical research to address critical...
The Leland Stanford Junior University received a $157,700 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research utilizing the immune response to tumor neoantigens for kidney cancer early detection. Through April 2022, Stanford University researchers will investigate medical solutions for the battlefield by exploring the potential of the body's immune response to detect and...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $370,866 formula grant to The Leland Stanford Junior University on April 1, 2025. The grant, titled "Uncovering Synthetically Lethal Genes in the Presence of Protein Folding Stress in Lung Cancer in vivo", will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The 1-year grant period will run through...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $131,655 to The Leland Stanford Junior University (Stanford University) to conduct research on identifying painful schwannomas using a sigma-1 receptor radioligand and PET/MRI imaging. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing biomedical capabilities in this area. The award period...